PFG
LLY icon

PAX Financial Group’s Eli Lilly LLY Stock Holding History

PAX Financial Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$899K Buy
977
+52
+6% +$52.7K 0.15% 93
2025
Q4 		$994K Buy
925
+63
+7% +$60.2K 0.17% 91
2025
Q3 		$658K Buy
862
+58
+7% +$43.2K 0.12% 118
2025
Q2 		$627K Sell
804
-293
-27% -$228K 0.12% 127
2025
Q1 		$906K Buy
1,097
+77
+8% +$64.1K 0.16% 110
2024
Q4 		$787K Buy
1,020
+167
+20% +$138K 0.14% 127
2024
Q3 		$756K Buy
853
+136
+19% +$122K 0.14% 133
2024
Q2 		$649K Buy
717
+259
+57% +$207K 0.13% 144
2024
Q1 		$356K Buy
458
+15
+3% +$10.7K 0.07% 190
2023
Q4 		$326K Buy
+443
New +$259K 0.07% 189
2022
Q2 		– Sell
-951
Closed -$272K – 188
2022
Q1 		$272K Sell
951
-485
-34% -$125K 0.06% 177
2021
Q4 		$397K Buy
1,436
+30
+2% +$7.61K 0.09% 147
2021
Q3 		$325K Buy
1,406
+486
+53% +$120K 0.08% 151
2021
Q2 		$211K Buy
+920
New +$185K 0.05% 161

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PAX Financial Group's LLY Position: Q1 2026 in Review

PAX Financial Group increased its Eli Lilly (LLY) stake by 5.6% in Q1 2026, buying an estimated $52.7K and bringing the position to 977 shares worth $899K. The position accounts for 0.15% of the portfolio, ranked #93.

PAX Financial Group first reported a position in LLY in Q2 2021 and has held it in 14 quarters since. The position peaked at $994K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • PAX Financial Group held 977 shares of Eli Lilly worth $899K as of Q1 2026.
  • PAX Financial Group bought 52 Eli Lilly shares in Q1 2026, an estimated $52.7K.
  • Eli Lilly made up 0.15% of PAX Financial Group's portfolio in Q1 2026, its #93 holding.
  • PAX Financial Group first reported a position in Eli Lilly in Q2 2021 and has held it in 14 quarters since.
  • PAX Financial Group's Eli Lilly position peaked at $994K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on PAX Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.